Stem cell therapy improves motor function in Parkinson’s trial, data show
XS411, Xellsmart ’s experimental stem cell therapy, was generally well tolerated and associated with improved motor function in people with Parkinson’s disease , according to new Phase 1 clinical trial data. The trial ( NCT07080775 ) enrolled nine people with moderate to advanced Parkinson’s. It als
Source: Parkinson's News Today.